Recognized standard

C37-A

FDA recognition 7-88 · CLSI · InVitro Diagnostics

Key facts

Recognition number 7-88
Designation C37-A
Title Preparation and Validation of Commutable Frozen Human Serum Pools as Secondary Reference Materials for Cholesterol Measurement Procedures; Approved Guideline
Standards developer Clinical Laboratory Standards Institute
Specialty area InVitro Diagnostics
Date of entry Mar 8, 2004
Device classes Class 2, Class 1
Scope (excerpt) This guideline details procedures for the manufacture and evaluation of human serum pools for cholesterol measurement.

At a glance

  • None Product codes
  • 1–9 FDA guidance documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA-recognized consensus standards

The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.

Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date:

Browse all FDA-recognized consensus standards